| Primary |
| Graft Versus Host Disease |
24.2% |
| Multiple Myeloma |
24.2% |
| Chemotherapy |
12.1% |
| Autologous Peripheral Hematopoietic Stem Cell Transplant |
9.1% |
| Bone Marrow Conditioning Regimen |
6.1% |
| Intraocular Retinoblastoma |
6.1% |
| Prophylaxis |
6.1% |
| Sarcoma |
6.1% |
| Stem Cell Transplant |
6.1% |
|
| Mesenteric Artery Thrombosis |
10.0% |
| Multi-organ Failure |
10.0% |
| Neutropenia |
10.0% |
| Polypoidal Choroidal Vasculopathy |
10.0% |
| Pulmonary Oedema |
10.0% |
| Retinal Detachment |
10.0% |
| Squamous Cell Carcinoma Of Skin |
10.0% |
| Stomatitis |
10.0% |
| Ulcer |
10.0% |
| Ventricular Arrhythmia |
10.0% |
|
| Secondary |
| Multiple Myeloma |
69.1% |
| Stem Cell Transplant |
5.6% |
| Bone Marrow Conditioning Regimen |
3.5% |
| Drug Use For Unknown Indication |
3.0% |
| Acute Myeloid Leukaemia |
2.8% |
| Non-hodgkin's Lymphoma |
2.1% |
| Acute Lymphocytic Leukaemia |
1.7% |
| Amyloidosis |
1.7% |
| Myeloma Recurrence |
1.2% |
| Prophylaxis |
1.1% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Myelodysplastic Syndrome |
0.9% |
| Neoplasm Progression |
0.9% |
| Neuroblastoma |
0.9% |
| Breast Cancer |
0.8% |
| Graft Versus Host Disease |
0.8% |
| Diffuse Large B-cell Lymphoma |
0.7% |
| Malignant Melanoma |
0.7% |
| Mantle Cell Lymphoma |
0.6% |
| Prophylaxis Against Graft Versus Host Disease |
0.6% |
|
| Pneumonia |
10.5% |
| Thrombocytopenia |
8.8% |
| Neutropenia |
7.9% |
| Vomiting |
7.0% |
| White Blood Cell Count Decreased |
7.0% |
| Post Procedural Complication |
5.3% |
| Staphylococcal Infection |
5.3% |
| Stem Cell Transplant |
5.3% |
| Sepsis |
4.4% |
| Septic Shock |
4.4% |
| Urticaria |
4.4% |
| Hypotension |
3.5% |
| Pulmonary Oedema |
3.5% |
| Respiratory Failure |
3.5% |
| Retinal Detachment |
3.5% |
| Vasculitis |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Weight Increased |
3.5% |
| Atrial Fibrillation |
2.6% |
| Colitis |
2.6% |
|
| Concomitant |
| Stem Cell Transplant |
33.8% |
| Multiple Myeloma |
25.9% |
| Chemotherapy |
4.6% |
| Chronic Lymphocytic Leukaemia |
4.6% |
| Bone Marrow Transplant |
3.2% |
| Plasma Cell Myeloma |
3.2% |
| Haematopoietic Stem Cell Mobilisation |
2.8% |
| Immunosuppression |
2.8% |
| Non-hodgkin's Lymphoma |
2.8% |
| Prophylaxis |
2.8% |
| Cord Blood Transplant Therapy |
2.3% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| B-cell Lymphoma |
1.4% |
| Graft Versus Host Disease |
1.4% |
| Neuroblastoma |
1.4% |
| Osteoporosis |
1.4% |
| Allogenic Bone Marrow Transplantation Therapy |
0.9% |
| Epstein-barr Virus Infection |
0.9% |
| Immunodeficiency |
0.9% |
| Myelodysplastic Syndrome |
0.9% |
|
| Vomiting |
23.5% |
| Stomatitis |
10.4% |
| Venoocclusive Liver Disease |
8.7% |
| White Blood Cell Count Decreased |
8.7% |
| Septic Shock |
5.2% |
| Thrombocytopenia |
5.2% |
| Weight Increased |
5.2% |
| Stem Cell Transplant |
4.3% |
| Encephalopathy |
2.6% |
| Fatigue |
2.6% |
| Myelodysplastic Syndrome |
2.6% |
| Rash |
2.6% |
| Renal Failure |
2.6% |
| Renal Failure Acute |
2.6% |
| Renal Impairment |
2.6% |
| Tooth Extraction |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Drug Ineffective |
1.7% |
| Graft Versus Host Disease |
1.7% |
| Graft Versus Host Disease In Lung |
1.7% |
|
